Short- and Long-Term Outcomes of Infliximab Treatment for Steroid-Refractory Ulcerative Colitis and Related Prognostic Factors: A Single-Center Retrospective Study-Reference-Cited by-同舟云学术

Short- and Long-Term Outcomes of Infliximab Treatment for Steroid-Refractory Ulcerative Colitis and Related Prognostic Factors: A Single-Center Retrospective Study

Published:2017 Issue:1 Volume:95 Page:67-71
ISSN:0012-2823
Container-title:Digestion
language:en
Short-container-title:Digestion

Author:

Nasuno Masanao,Miyakawa Maki,Tanaka Hiroki,Motoya Satoshi

Publisher

S. Karger AG

Subject

Gastroenterology

Reference18 articles.

1. Ulcerative Colitis

2. Long-Term Colectomy Rate After Intensive Intravenous Corticosteroid Therapy for Ulcerative Colitis Prior to the Immunosuppressive Treatment Era

3. Immunology of Crohn's Disease

4. Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

5. Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex and age differences in inflammatory bowel disease patients; a nationwide study based on Iranian Registry of Crohn’s and Colitis (IRCC);PLOS ONE;2024-07-11

2. Multicenter registry of pediatric inflammatory bowel disease from a developing country;BMC Pediatrics;2024-04-01

3. Gender-specific medicine in chronic inflammatory bowel disease;Die Gastroenterologie;2023-11-30

4. Sex- and gender-related differences in inflammatory bowel diseases;Frontiers in Gastroenterology;2023-10-03

5. Predictors and optimal management of tumor necrosis factor antagonist nonresponse in inflammatory bowel disease: A literature review;World Journal of Gastroenterology;2023-08-07